Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients

Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determi...

Full description

Saved in:
Bibliographic Details
Published inKorean journal of anesthesiology Vol. 58; no. 4; pp. 338 - 343
Main Authors Huh, Billy, Park, Chan-Hong
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Anesthesiologists 01.04.2010
Korean Society of Anesthesiologists
대한마취통증의학회
Subjects
Online AccessGet full text
ISSN2005-6419
2005-7563
2005-7563
DOI10.4097/kjae.2010.58.4.338

Cover

Abstract Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated. A total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected. The QTc interval was significantly longer in the treatment group than in the control group (443 +/- 30.0 ms versus 408 +/- 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822). This study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants.
AbstractList Background: Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated. Methods: A total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected. Results: The QTc interval was significantly longer in the treatment group than in the control group (443 ± 30.0 ms versus 408 ± 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822). Conclusions: This study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants. KCI Citation Count: 0
BackgroundMethadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated.MethodsA total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected.ResultsThe QTc interval was significantly longer in the treatment group than in the control group (443 ± 30.0 ms versus 408 ± 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822).ConclusionsThis study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants.
Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated.BACKGROUNDMethadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated.A total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected.METHODSA total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected.The QTc interval was significantly longer in the treatment group than in the control group (443 +/- 30.0 ms versus 408 +/- 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822).RESULTSThe QTc interval was significantly longer in the treatment group than in the control group (443 +/- 30.0 ms versus 408 +/- 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822).This study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants.CONCLUSIONSThis study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants.
Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation or which can lead to torsades de pointes has been confirmed with larger studies on high dose methadone. The aim of this study was to determine the effect of methadone on the QTc interval in patients, whether the daily dose of methadone should be lower than what has been previously investigated. A total of 130 patients were included, with 90 patients in the methadone group and 40 patients in the control group. For each ECG, heart rate, QT interval and corrected QT (QTc) interval were recorded. The patient demographics, methadone dose and serum level, duration of methadone use and past medical history were collected. The QTc interval was significantly longer in the treatment group than in the control group (443 +/- 30.0 ms versus 408 +/- 28.0 ms, respectively, P < 0.0001) and more patients in the treatment group had a QTc interval greater than 450 ms (36.7% versus 7.5%, respectively, P = 0.0005). The QTc interval was not associated with methadone dose P = 0.9278), serum level (P = 0.2256) or duration of treatment (P = 0.1822). This study has shown that methadone use is associated with longer QTc intervals, even among patients with daily doses of less than 80 mg. In this study, no correlation was found between QTc duration and methadone dose, serum levels or duration of use. However, the magnitude of the QTc interval was associated with female gender and the use of antidepressants.
Author Park, Chan-Hong
Huh, Billy
AuthorAffiliation 1 Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA
2 Deaprtment of Anesthesiology and Pain Medicine, Daegu Wooridul Hospital, Daegu, Korea
AuthorAffiliation_xml – name: 2 Deaprtment of Anesthesiology and Pain Medicine, Daegu Wooridul Hospital, Daegu, Korea
– name: 1 Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA
Author_xml – sequence: 1
  givenname: Billy
  surname: Huh
  fullname: Huh, Billy
  organization: Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA
– sequence: 2
  givenname: Chan-Hong
  surname: Park
  fullname: Park, Chan-Hong
  organization: Deaprtment of Anesthesiology and Pain Medicine, Daegu Wooridul Hospital, Daegu, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20508789$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001439029$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9Uk1v1DAQjVARLaV_gAPKDS5ZHDvxxwWpqvhYqRKiWi5crIk92fVu1g52tqj_Hu9HEeWAL-OZefOerXkvizMfPBbF65rMGqLE-80acEZJTls5a2aMyWfFBSWkrUTL2dnpzptanRdXKa1JPowRwumL4pySlkgh1UXx4w6nGNKIZnL3WIKH4SG5VIa-HMKvyoaE5RanFdgsn9u2_LYw5RjDEPwSJhd86XxpVjF4l-uQkzGX0U_pVfG8hyHh1SleFt8_fVzcfKluv36e31zfVqYlZKqo4BQYp1xZwbsWaQsdk71VjaLKEMsawhppubA1BdEIUAKl6iRirWTXEnZZvDvy-tjrjXE6gDvEZdCbqK_vFnMtKGeSZuj8CLUB1nqMbgvx4YA_FEJcaoiTMwNqhgLAMlXXKBvTdaC6DpE0CJRL0pnM9eHINe66LVqTvxxheEL6tOPdKj_pXlMpuGxZJnh7Iojh5w7TpLcuGRwG8Bh2SQvGaqKIUBn55m-pPxqPa8wAeQSYvMsUsdfGTYftZGU36JrovWn03jR6bxrdSt3obJo8Sv8ZfWT_z9BvXuHGpA
CitedBy_id crossref_primary_10_5812_rijm_13642
crossref_primary_10_1097_MPH_0000000000001444
crossref_primary_10_1002_jcph_1999
crossref_primary_10_1111_pme_12658
crossref_primary_10_1186_s12916_014_0178_2
crossref_primary_10_1080_10550887_2013_824333
crossref_primary_10_1016_j_jpainsymman_2013_09_021
crossref_primary_10_1111_pme_12795
crossref_primary_10_34172_jsums_702
crossref_primary_10_1080_17581869_2025_2457316
crossref_primary_10_1007_s12012_018_9474_y
crossref_primary_10_4137_PMC_S6803
crossref_primary_10_1093_bja_aet412
crossref_primary_10_1111_j_1540_8167_2011_02231_x
crossref_primary_10_1016_j_jcrc_2016_03_023
crossref_primary_10_4103_jrpp_jrpp_49_24
crossref_primary_10_1155_2014_341826
crossref_primary_10_1016_j_jpain_2014_01_495
crossref_primary_10_1093_jbcr_irz200
crossref_primary_10_3109_00952990_2013_804525
crossref_primary_10_1007_s12501_012_0006_3
crossref_primary_10_1213_ANE_0000000000006790
crossref_primary_10_1089_jpm_2016_0411
crossref_primary_10_1111_j_1360_0443_2011_03767_x
crossref_primary_10_1177_1049909118811904
crossref_primary_10_1517_14656566_2012_682150
crossref_primary_10_1053_j_jvca_2020_12_011
crossref_primary_10_1097_NCI_0b013e318220c504
Cites_doi 10.1056/NEJMra032426
10.1016/j.jpainsymman.2004.06.012
10.1016/S0304-3959(02)00461-X
10.1016/S0002-9149(03)00906-8
10.1001/jama.289.16.2120
10.1016/S0008-6363(02)00846-5
10.1016/S0022-3565(24)29321-6
10.1001/archinte.166.12.1280
10.1159/000081416
10.1124/jpet.102.038240
10.7326/0003-4819-139-2-200307150-00021
10.1592/phco.2005.25.11.1523
10.1111/j.1525-1497.2006.00588.x
10.1002/pds.1112
10.1016/S0002-9149(02)02337-8
10.1111/j.1360-0443.2006.01668.x
10.1016/S0304-3959(03)00205-7
10.7326/0003-4819-137-6-200209170-00010
10.1007/s00134-004-2335-0
10.7326/0003-4819-139-2-200307150-00021-w2
10.1097/01.jcp.0000132347.81455.57
10.1016/j.amjcard.2004.11.055
10.2165/00003088-199937010-00002
ContentType Journal Article
Copyright Copyright © The Korean Society of Anesthesiologists, 2010 2010
Copyright_xml – notice: Copyright © The Korean Society of Anesthesiologists, 2010 2010
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
ACYCR
DOI 10.4097/kjae.2010.58.4.338
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2005-7563
EndPage 343
ExternalDocumentID oai_kci_go_kr_ARTI_726382
oai_doaj_org_article_3e7aad3911e84cbba9bbee04ea2680bc
PMC2876853
20508789
10_4097_kjae_2010_58_4_338
Genre Journal Article
GroupedDBID 5-W
53G
8JR
8XY
9ZL
AAYXX
ABDBF
ACUHS
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
CITATION
DIK
E3Z
EBD
EF.
ESX
F5P
GROUPED_DOAJ
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
TUS
NPM
7X8
5PM
ABPTK
ACYCR
HZB
ID FETCH-LOGICAL-c500t-2762a36269d76b5e25ab38fd94929c0d340348d67d12a747a97e89b8ee198b503
IEDL.DBID DOA
ISSN 2005-6419
2005-7563
IngestDate Tue Nov 21 21:27:32 EST 2023
Wed Aug 27 01:31:20 EDT 2025
Thu Aug 21 14:12:21 EDT 2025
Fri Sep 05 04:18:28 EDT 2025
Thu Apr 03 07:09:51 EDT 2025
Thu Apr 24 23:10:19 EDT 2025
Tue Jul 01 05:40:28 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Opioid
QT interval
Methadone
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c500t-2762a36269d76b5e25ab38fd94929c0d340348d67d12a747a97e89b8ee198b503
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000679.2010.58.4.011
OpenAccessLink https://doaj.org/article/3e7aad3911e84cbba9bbee04ea2680bc
PMID 20508789
PQID 733109079
PQPubID 23479
PageCount 6
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_726382
doaj_primary_oai_doaj_org_article_3e7aad3911e84cbba9bbee04ea2680bc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2876853
proquest_miscellaneous_733109079
pubmed_primary_20508789
crossref_citationtrail_10_4097_kjae_2010_58_4_338
crossref_primary_10_4097_kjae_2010_58_4_338
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-04-01
PublicationDateYYYYMMDD 2010-04-01
PublicationDate_xml – month: 04
  year: 2010
  text: 2010-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Korean journal of anesthesiology
PublicationTitleAlternate Korean J Anesthesiol
PublicationYear 2010
Publisher The Korean Society of Anesthesiologists
Korean Society of Anesthesiologists
대한마취통증의학회
Publisher_xml – name: The Korean Society of Anesthesiologists
– name: Korean Society of Anesthesiologists
– name: 대한마취통증의학회
References Martell (10.4097/kjae.2010.58.4.338_ref12) 2005; 95
Bednar (10.4097/kjae.2010.58.4.338_ref23) 2002; 89
(10.4097/kjae.2010.58.4.338_ref1) 1997; 15
Gil (10.4097/kjae.2010.58.4.338_ref7) 2003; 92
Martell (10.4097/kjae.2010.58.4.338_ref13) 2003; 139
Decerf (10.4097/kjae.2010.58.4.338_ref2) 2004; 30
Lamont (10.4097/kjae.2010.58.4.338_ref3) 2006; 21
Walker (10.4097/kjae.2010.58.4.338_ref4) 2003; 103
Ehret (10.4097/kjae.2010.58.4.338_ref11) 2006; 166
Katchman (10.4097/kjae.2010.58.4.338_ref17) 2002; 303
Kornick (10.4097/kjae.2010.58.4.338_ref15) 2003; 105
Redfern (10.4097/kjae.2010.58.4.338_ref21) 2003; 58
Ferreira (10.4097/kjae.2010.58.4.338_ref20) 2001; 299
Pearson (10.4097/kjae.2010.58.4.338_ref16) 2005; 14
Al-Khatib (10.4097/kjae.2010.58.4.338_ref19) 2003; 289
Krantz (10.4097/kjae.2010.58.4.338_ref5) 2002; 137
Tegeder (10.4097/kjae.2010.58.4.338_ref18) 1999; 37
Krantz (10.4097/kjae.2010.58.4.338_ref14) 2005; 25
Maremmani (10.4097/kjae.2010.58.4.338_ref24) 2005; 11
Cruciani (10.4097/kjae.2010.58.4.338_ref9) 2005; 29
Roden (10.4097/kjae.2010.58.4.338_ref22) 2004; 350
Piguet (10.4097/kjae.2010.58.4.338_ref8) 2004; 24
De Bels (10.4097/kjae.2010.58.4.338_ref6) 2003; 139
Peles (10.4097/kjae.2010.58.4.338_ref10) 2007; 102
16801510 - Arch Intern Med. 2006 Jun 26;166(12):1280-7
12859181 - Ann Intern Med. 2003 Jul 15;139(2):E156
12230351 - Ann Intern Med. 2002 Sep 17;137(6):501-4
17026725 - J Gen Intern Med. 2006 Nov;21(11):C9-C12
15185068 - Intensive Care Med. 2004 Aug;30(8):1690-1
12388652 - J Pharmacol Exp Ther. 2002 Nov;303(2):688-94
15918160 - Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):747-53
17222284 - Addiction. 2007 Feb;102(2):289-300
12859171 - Ann Intern Med. 2003 Jul 15;139(2):154-5
12031739 - Am J Cardiol. 2002 Jun 1;89(11):1316-9
14999113 - N Engl J Med. 2004 Mar 4;350(10):1013-22
11561083 - J Pharmacol Exp Ther. 2001 Oct;299(1):220-6
12791438 - Pain. 2003 Jun;103(3):321-4
15857742 - J Pain Symptom Manage. 2005 Apr;29(4):385-91
15232338 - J Clin Psychopharmacol. 2004 Aug;24(4):446-8
16232014 - Pharmacotherapy. 2005 Nov;25(11):1523-9
12709470 - JAMA. 2003 Apr 23-30;289(16):2120-7
12667944 - Cardiovasc Res. 2003 Apr 1;58(1):32-45
15781034 - Am J Cardiol. 2005 Apr 1;95(7):915-8
15608471 - Eur Addict Res. 2005;11(1):44-9
14556883 - Am J Cardiol. 2003 Oct 15;92(8):995-7
10451781 - Clin Pharmacokinet. 1999 Jul;37(1):17-40
14527710 - Pain. 2003 Oct;105(3):499-506
References_xml – volume: 350
  start-page: 1013
  year: 2004
  ident: 10.4097/kjae.2010.58.4.338_ref22
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra032426
– volume: 29
  start-page: 385
  year: 2005
  ident: 10.4097/kjae.2010.58.4.338_ref9
  publication-title: J Pain Symptom Manage
  doi: 10.1016/j.jpainsymman.2004.06.012
– volume: 103
  start-page: 321
  year: 2003
  ident: 10.4097/kjae.2010.58.4.338_ref4
  publication-title: Pain
  doi: 10.1016/S0304-3959(02)00461-X
– volume: 92
  start-page: 995
  year: 2003
  ident: 10.4097/kjae.2010.58.4.338_ref7
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(03)00906-8
– volume: 289
  start-page: 2120
  year: 2003
  ident: 10.4097/kjae.2010.58.4.338_ref19
  publication-title: JAMA
  doi: 10.1001/jama.289.16.2120
– volume: 58
  start-page: 32
  year: 2003
  ident: 10.4097/kjae.2010.58.4.338_ref21
  publication-title: Cardiovasc Res
  doi: 10.1016/S0008-6363(02)00846-5
– volume: 299
  start-page: 220
  year: 2001
  ident: 10.4097/kjae.2010.58.4.338_ref20
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(24)29321-6
– volume: 166
  start-page: 1280
  year: 2006
  ident: 10.4097/kjae.2010.58.4.338_ref11
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.166.12.1280
– volume: 11
  start-page: 44
  year: 2005
  ident: 10.4097/kjae.2010.58.4.338_ref24
  publication-title: Eur Addict Res
  doi: 10.1159/000081416
– volume: 303
  start-page: 688
  year: 2002
  ident: 10.4097/kjae.2010.58.4.338_ref17
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.102.038240
– volume: 139
  start-page: 154
  year: 2003
  ident: 10.4097/kjae.2010.58.4.338_ref13
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-139-2-200307150-00021
– volume: 25
  start-page: 1523
  year: 2005
  ident: 10.4097/kjae.2010.58.4.338_ref14
  publication-title: Pharmacotherapy
  doi: 10.1592/phco.2005.25.11.1523
– volume: 21
  start-page: C9
  year: 2006
  ident: 10.4097/kjae.2010.58.4.338_ref3
  publication-title: J Gen Intern Med
  doi: 10.1111/j.1525-1497.2006.00588.x
– volume: 14
  start-page: 747
  year: 2005
  ident: 10.4097/kjae.2010.58.4.338_ref16
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1112
– volume: 89
  start-page: 1316
  year: 2002
  ident: 10.4097/kjae.2010.58.4.338_ref23
  publication-title: Am J Cardiol
  doi: 10.1016/S0002-9149(02)02337-8
– volume: 102
  start-page: 289
  year: 2007
  ident: 10.4097/kjae.2010.58.4.338_ref10
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2006.01668.x
– volume: 105
  start-page: 499
  year: 2003
  ident: 10.4097/kjae.2010.58.4.338_ref15
  publication-title: Pain
  doi: 10.1016/S0304-3959(03)00205-7
– volume: 137
  start-page: 501
  year: 2002
  ident: 10.4097/kjae.2010.58.4.338_ref5
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-137-6-200209170-00010
– volume: 30
  start-page: 1690
  year: 2004
  ident: 10.4097/kjae.2010.58.4.338_ref2
  publication-title: Intensive Care Med
  doi: 10.1007/s00134-004-2335-0
– volume: 139
  start-page: E156
  year: 2003
  ident: 10.4097/kjae.2010.58.4.338_ref6
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-139-2-200307150-00021-w2
– volume: 24
  start-page: 446
  year: 2004
  ident: 10.4097/kjae.2010.58.4.338_ref8
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/01.jcp.0000132347.81455.57
– volume: 15
  start-page: 1
  year: 1997
  ident: 10.4097/kjae.2010.58.4.338_ref1
  publication-title: NIH Consens Statement Online
– volume: 95
  start-page: 915
  year: 2005
  ident: 10.4097/kjae.2010.58.4.338_ref12
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.11.055
– volume: 37
  start-page: 17
  year: 1999
  ident: 10.4097/kjae.2010.58.4.338_ref18
  publication-title: Clin Pharmacokinet
  doi: 10.2165/00003088-199937010-00002
– reference: 15918160 - Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):747-53
– reference: 12859181 - Ann Intern Med. 2003 Jul 15;139(2):E156
– reference: 12667944 - Cardiovasc Res. 2003 Apr 1;58(1):32-45
– reference: 12230351 - Ann Intern Med. 2002 Sep 17;137(6):501-4
– reference: 17222284 - Addiction. 2007 Feb;102(2):289-300
– reference: 12031739 - Am J Cardiol. 2002 Jun 1;89(11):1316-9
– reference: 16232014 - Pharmacotherapy. 2005 Nov;25(11):1523-9
– reference: 11561083 - J Pharmacol Exp Ther. 2001 Oct;299(1):220-6
– reference: 15857742 - J Pain Symptom Manage. 2005 Apr;29(4):385-91
– reference: 15185068 - Intensive Care Med. 2004 Aug;30(8):1690-1
– reference: 16801510 - Arch Intern Med. 2006 Jun 26;166(12):1280-7
– reference: 14527710 - Pain. 2003 Oct;105(3):499-506
– reference: 12859171 - Ann Intern Med. 2003 Jul 15;139(2):154-5
– reference: 15608471 - Eur Addict Res. 2005;11(1):44-9
– reference: 12388652 - J Pharmacol Exp Ther. 2002 Nov;303(2):688-94
– reference: 15232338 - J Clin Psychopharmacol. 2004 Aug;24(4):446-8
– reference: 15781034 - Am J Cardiol. 2005 Apr 1;95(7):915-8
– reference: 12709470 - JAMA. 2003 Apr 23-30;289(16):2120-7
– reference: 17026725 - J Gen Intern Med. 2006 Nov;21(11):C9-C12
– reference: 10451781 - Clin Pharmacokinet. 1999 Jul;37(1):17-40
– reference: 14999113 - N Engl J Med. 2004 Mar 4;350(10):1013-22
– reference: 12791438 - Pain. 2003 Jun;103(3):321-4
– reference: 14556883 - Am J Cardiol. 2003 Oct 15;92(8):995-7
SSID ssj0000330062
Score 1.9540086
Snippet Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval prolongation...
BackgroundMethadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval...
Background: Methadone is a synthetic opioid that is widely used for the treatment of chronic pain. The association between methadone treatment and QT interval...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 338
SubjectTerms Clinical
methadone
opioid
qt interval
마취과학
SummonAdditionalLinks – databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELaW5cIFgXiFl4zEDaW4iZ8nBIjVgrRIoK204mL5Wbqt4iXtCvj3jJ20omjhxClK7CTOjD0znzL-BqHnKjJpaXQ1lxEASnCkNsS4mojIGiqC9aV6w8lHfjyjH87Y2QHaljsaBbi-EtrlelKzfjX58e3nK1jwEL9OMlvTy-W5CUOSFpMTOgHQdQ1dB8_EMxg7GcP9YpkBvJNSY7QQcHI6VcM-mr88Zs9XFUp_8EBdH6-KRv9MqvzNSx3dQjfH8BK_HubDbXQQujvoy-ew6dN2TyU2Iw8JThGv0vfap3XAuZK08anLzR5_OnUY3r1K3bxoDi867AYaXXxh4GSkY13fRbOjd6dvj-uxpkLtGCGbugHjZzIFjfKCWxYaZmwro1cU4iRHfEtJS6Xnwk8bA1DDKBGksjKEqZKWkfYeOuxgMA8Q9r51pLVWOW4p2AVDKLXCcQWTIkobKzTdSk-7kXA8171YaQAeWeI6S1xniWsmNdUg8Qq92N1zMdBt_LP3m6yUXc9MlV0upH6ux5Wn2yCM8S0Y9SCps9Yoa0MgNJiGS2JdhZ6BSvXSLcr9-ThPetlrABTvtWjAQDUVwluFa1h--Z-K6UK6XOtc8pIoIlSF7g_6342mIRD8CgktYm9m7A13v6VbfC0M3wBjOcRRD__H9z1CN4aMh5xt9BgdbvrL8AQCqY19WlbHL-2hHSE
  priority: 102
  providerName: Scholars Portal
Title Retrospective analysis of low-dose methadone and QTc prolongation in chronic pain patients
URI https://www.ncbi.nlm.nih.gov/pubmed/20508789
https://www.proquest.com/docview/733109079
https://pubmed.ncbi.nlm.nih.gov/PMC2876853
https://doaj.org/article/3e7aad3911e84cbba9bbee04ea2680bc
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001439029
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Korean Journal of Anesthesiology, 2010, 58(4), , pp.338-343
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxQxFA_SUy-i-DVaSwRvMm128n1si6UKFZQWipeQz7ruMlN2t_jv-5LMLrtF9OJlhpkkTPLey_tgXn4Pofc6ceVY8q1QCQKU6ElrifUtkYl3TEYXSvWGyy_i4pp9vuE3W6W-ck5YhQeuhDumUVobKOzJqJh3zmrnYiQs2k4o4nzWvkSTrWCq6GAI00mpJlqgNgWb6HpiJsM7Hc9-2lizurg6Ykc0H07ZskoFvB9sTb9If_I7H6ZPbtmj8yfo8ehI4pO6gKfoUeyfoe_f4moxrE9PYjsijuAh4fnwqw3DMuJcM9qGoc_NAX-98hi-PR_628IjPO2xr4C5-M7Cwwi8unyOrs8_Xp1dtGP1hNZzQlZtB2rOZrAZHaRwPHbcOqpS0Aw8Ik8CZYQyFYQMk85CUGG1jEo7FeNEK8cJfYH2epjMK4RDoJ5Q57QXjoEGsIQxJ73QwP6kXGrQZE0940do8VzhYm4gxMgUN5niJlPccGWYAYo36MNmzF0F1vhr79PMlE3PDIpdXoComFFUzL9EpUHvgKVm5qdlfL7fDma2MBA6fDKyA1XUNQivGW5go-W_J7aPw_3S5OKWIGhSN-hl5f9mNh0BN1cqaJE7krEz3d2WfvqjYHlDwCrAY3r9P9b3Bu3X3IacV3SA9laL-_gWXKaVOyy7A66XTP0GXmQWow
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Retrospective+analysis+of+low-dose+methadone+and+QTc+prolongation+in+chronic+pain+patients&rft.jtitle=Korean+journal+of+anesthesiology&rft.au=Billy+Huh&rft.au=Chan-Hong+Park&rft.date=2010-04-01&rft.pub=Korean+Society+of+Anesthesiologists&rft.issn=2005-6419&rft.eissn=2005-7563&rft.volume=58&rft.issue=4&rft.spage=338&rft.epage=343&rft_id=info:doi/10.4097%2Fkjae.2010.58.4.338&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_3e7aad3911e84cbba9bbee04ea2680bc
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-6419&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-6419&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-6419&client=summon